Dupont Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Dupont Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,937	Closed	-$647K	–	1779
2021 Q1	$647K	Buy	+3,937	New	+$648K	0.02%	807
2019 Q3	–	Sell	-9,613	Closed	-$1.37M	–	1231
2019 Q2	$1.37M	Sell	9,613 -357	-4%	-$48K	0.03%	461
2019 Q1	$1.43M	Buy	+9,970	New	+$1.3M	0.03%	445
2016 Q3	–	Sell	-7,500	Closed	-$1.06M	–	679
2016 Q2	$1.06M	Sell	7,500 -3,000	-29%	-$442K	0.02%	434
2016 Q1	$1.37M	Buy	+10,500	New	+$1.31M	0.03%	387
2015 Q3	–	Sell	-2,517	Closed	-$443K	–	615
2015 Q2	$443K	Sell	2,517 -5,210	-67%	-$936K	0.01%	526
2015 Q1	$1.33M	Sell	7,727 -14,863	-66%	-$2.55M	0.03%	416
2014 Q4	$3.7M	Buy	22,590 +11,051	+96%	+$1.83M	0.07%	239
2014 Q3	$1.85M	Sell	11,539 -2,397	-17%	-$369K	0.03%	343
2014 Q2	$2.05M	Sell	13,936 -10,372	-43%	-$1.44M	0.03%	365
2014 Q1	$3.37M	Sell	24,308 -27,191	-53%	-$4.09M	0.05%	266
2013 Q4	$6.52M	Sell	51,499 -5,216	-9%	-$540K	0.11%	148
2013 Q3	$5.22M	Sell	56,715 -51,343	-48%	-$4.14M	0.1%	192
2013 Q2	$7.43M	Buy	+108,058	New	+$6.6M	0.14%	133

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dupont Capital Management's JAZZ Position: Q2 2021 in Review

Dupont Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 3,937 shares — an estimated $647K sold.

Dupont Capital Management first reported a position in JAZZ in Q2 2013 and held it in 14 quarters. The position peaked at $7.43M in Q2 2013. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

Dupont Capital Management reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Dupont Capital Management sold 3,937 Jazz Pharmaceuticals shares in Q2 2021, an estimated $647K.
Dupont Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Dupont Capital Management's Jazz Pharmaceuticals position peaked at $7.43M in Q2 2013.
505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.